-
Precision Nutrition, Circadian Fasting, and Renal Cell Carcinoma
15 Jul 2025 11:34 GMT
… , body composition, and metabolomics impact renal cell carcinoma treatment outcomes. With over $30 million … these tissues when patients undergo treatment for renal cell carcinoma. Are there changes in …
-
Evaluating Efficacy of Second-Line RCC Treatments Post-Immunotherapy
15 Jul 2025 13:04 GMT
… indolent metastatic clear cell renal cell carcinoma (RCC) status post left … treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug … interactions of anti-angiogenic drugs. Cancer …
-
Ovarian Cancer Drugs Market to Hit $7.2 Billion by 2035, Driven by Rising FDA Approvals and 2024's $4.2 Billion Base
14 Jul 2025 07:02 GMT
… share for the ovarian cancer treatment drugs market with robust clinical … and Drug Administration to mirvetuximab-soravtansine-gynx (Elahere). The medication is … cancer, recurrent glioblastoma, metastatic renal cell carcinoma, non-squamous non-small cell …
-
Non-Small Cell Lung Cancer Market: Valued at $18.8 Billion in 2024, Expected to Grow at 6.9% CAGR Through 2035
15 Jul 2025 07:59 GMT
… provide high-precision diagnostics, personalized treatment, and complete care.
Order … , metastatic colorectal cancer, metastatic renal cell carcinoma, recurrent glioblastoma, advanced cervical … ’s targeted CD228 antibody-drug conjugate BA1302 was granted …
-
RCC Treatment Selection Should Incorporate Patient Discussion and Goals
09 Jul 2025 04:06 GMT
-
Dr Chehrazi-Raffle on Tivozanib With/Without Nivolumab in Metastatic RCC
10 Jul 2025 03:19 GMT
… the analysis, patients with metastatic renal cell carcinoma (RCC) received either single-agent tivozanib … combination with nivolumab (Opdivo) following treatment with nivolumab and ipilimumab (Yervoy …
-
Dr Haas on the Safety Profile of Adjuvant Pembrolizumab in Clear Cell RCC
09 Jul 2025 02:16 GMT
… in patients with clear cell renal cell carcinoma.
Findings presented during the … arms experienced AEs leading to treatment discontinuation (21.1% vs … 11.5%), any-grade treatment-related AEs (TRAEs; 79 … .2%), TRAEs leading to treatment discontinuation (18.2% vs …
-
Mechanisms of Microctis Folium in Hyperlipidemia: Integrating Serum Pharmacochemistry, Network Pharmacology, and Transcriptomics
11 Jul 2025 13:28 GMT
… activity. Chin Tradit Herbal Drugs. 2019;50(24):5995 … Tibetan medicine Qiwei Tiexie pills on liver injury … pentaphyllum inducing apoptosis of renal cell carcinoma by PI3K/AKT … Pill in the treatment of diabetic nephropathy based on Yin-Yang theory. Drug …
-
Management of Von Hippel-Lindau Syndrome
10 Jul 2025 10:39 GMT
… three years for treatment of VHL-associated tumors including renal cell carcinoma, CNS hemangioblastomas … ,38 This is a systemic drug that can be administered orally … for renal cell carcinoma in von Hippel-Lindau disease. N Engl J Med 2021 …
-
Metformin Activation of Sirtuin 3 Signaling Regulates Mitochondrial Function Improves Diabetes-Associated Cognitive Impairment
11 Jul 2025 13:27 GMT
… renal cell carcinoma, thereby exerting the disease amelioration of the drug. … completion of the MET drug treatment regimen, all mice were … depression. J Cell Mol Med. 2021;25(15):7342 … suppresses human clear cell renal cell carcinoma growth and metastasis by …
About
© 1995-2025